Skip to content

Pilot trial on safety, feasibility and effectiveness of Osteopathic MANipulative Treatment following major abdominal surgery

Pilot trial on safety, feasibility and effectiveness of Osteopathic MANipulative Treatment following major abdominal surgery - OMANT-Pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007800
Enrollment
20
Registered
2015-02-10
Start date
2015-02-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after open or laparoscopic elective bowel resection

Interventions

Group 1: Intervention group: daily treatment with three different techniques (each about 30 minutes) of osteopathy for 5 days. Group 2: Control group: no-osteopathic manual treatment.

Sponsors

Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: - Open or laparoscopic elective bowel resection (with / without resection of other organs) - Age 18 to 90 years

Exclusion criteria

Exclusion criteria: - Diseases of the spine - Metastatic cancer - Preoperative medication with opiates - Minors - Inability to give informed consent

Design outcomes

Primary

MeasureTime frame
Pilot study without primary endpoint. General endpoints: - Mortality and morbidity until discharge (to Clavien-Dindo) - Complications caused by the intervention (quantitative and qualitative) - Problems in the implementation of the intervention (quantitative and qualitative) - Pain caused by intervention (NRS; before and after each treatment) - Length of stay (in days in intensive care and general ward) - Time to first bowel movement (hours postoperatively) - Time to first flatus (hours postoperatively) - Time to tolerance of solid food (postoperative day) - Vomiting (events in the first five days) - Pain (NRS; at each postoperative day until postoperative day 5) - Pain medication use (in mg for each drug until postoperative day 5) - Postoperative quality of life (PQL, pre-op, post-operative day 5, dismissal)

Secondary

MeasureTime frame
Pilot study without secondary endpoints, for objective criteria see previous item

Countries

Germany

Contacts

Public ContactPascal Probst

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie

pascal.probst@med.uni-heidelberg.de06221-5636337

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026